SKTO Stock Overview
SK3 Group, Inc. provides management advisory, licensing, and marketing services for medical marijuana collectives in California.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
SK3 Group, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.000001 |
| 52 Week High | US$0.0001 |
| 52 Week Low | US$0.000001 |
| Beta | 0 |
| 1 Month Change | 0% |
| 3 Month Change | 0% |
| 1 Year Change | 0% |
| 3 Year Change | -99.67% |
| 5 Year Change | 0% |
| Change since IPO | -100.00% |
Recent News & Updates
Recent updates
Shareholder Returns
| SKTO | US Healthcare | US Market | |
|---|---|---|---|
| 7D | 0% | 2.0% | 1.2% |
| 1Y | 0% | 3.4% | 24.9% |
Return vs Industry: SKTO underperformed the US Healthcare industry which returned 3.6% over the past year.
Return vs Market: SKTO underperformed the US Market which returned 24.7% over the past year.
Price Volatility
| SKTO volatility | |
|---|---|
| SKTO Average Weekly Movement | n/a |
| Healthcare Industry Average Movement | 7.2% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.6% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: SKTO's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine SKTO's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2000 | n/a | Artemus Mayor | n/a |
SK3 Group, Inc. provides management advisory, licensing, and marketing services for medical marijuana collectives in California. It licenses various products for marketing and sale, including the YAK line of medical marijuana edibles; Canna-Loz, a delivery system for large doses of phyto-cannabinoids; Yeti, a pre-roll for pain relief; and Dharmanol, a proprietary technology that extracts, stabilizes, and preserves the medicinal cannabinoids found in hemp and marijuana in their non-psychoactive form. The company was formerly known as CTT International Distributors, Inc. and changed its name to SK3 Group, Inc. in May 2007.
SK3 Group, Inc. Fundamentals Summary
| SKTO fundamental statistics | |
|---|---|
| Market cap | US$1.24k |
| Earnings (TTM) | US$22.20k |
| Revenue (TTM) | US$7.95m |
0.0x
P/E Ratio0.0x
P/S RatioIs SKTO overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| SKTO income statement (TTM) | |
|---|---|
| Revenue | US$7.95m |
| Cost of Revenue | US$2.24m |
| Gross Profit | US$5.72m |
| Other Expenses | US$5.69m |
| Earnings | US$22.20k |
Last Reported Earnings
Dec 31, 2010
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did SKTO perform over the long term?
See historical performance and comparison